BIOSIM Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Sep 20, 2019)
Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act
This bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified.
What just happenedSep 23, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseSep 20, 2019
- Sep 23, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 20, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 20, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Sep 20, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Sep 20, 2019IntroReferralIntro-H
Introduced in House
- Sep 20, 2019IntroReferral1000
Introduced in House